BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/28/2020 10:02:57 AM | Browse: 80 | Download: 54
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 51979
Country/Territory South Korea
2019-10-11 09:26
Peer-Review Started
2019-10-11 09:26
To Make the First Decision
Return for Revision
2019-11-11 17:23
2019-11-18 00:44
Second Decision
2019-12-30 09:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-12-31 04:31
Articles in Press
2019-12-31 04:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-02-13 08:30
Publish the Manuscript Online
2020-02-15 12:32
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
Manuscript Source Unsolicited Manuscript
All Author List In Rae Cho, Huapyong Kang, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Chansik An, Mi-Suk Park and Seungmin Bang
Funding Agency and Grant Number
Corresponding author Seungmin Bang, MD, PhD, Professor, Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Select, South Korea. bang7028@yuhs.ac
Keywords Pancreatic cancer; Chemotherapy; FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Survival
Core Tip Both FOLFIRINOX and gemcitabine plus nab-paclitaxel combination therapy are widely used as a treatment of choice in patients with metastatic pancreatic cancer. However, the treatment choice and sequence are not firmly established. In addition, researches on Asian populations in this regard are scarce. In the present study, we compared the treatment efficacy, safety, and economic aspects of FOLFIRINOX and gemcitabine plus nab-paclitaxel combination therapy. We believe that this study can help physicians and patients to select appropriate regimens while avoiding and preventing unnecessary complications.
Publish Date 2020-02-15 12:32
Citation Cho IR, Kang H, Jo JH, Lee HS, Chung MJ, Park JY, Park SW, Song SY, An C, Park MS, Bang S. FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study. World J Gastrointest Oncol 2020; 12(2): 182-194
Url https://www.wjgnet.com/1948-5204/full/v12/i2/182.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i2.182
Full Article (PDF) WJGO-12-182.pdf
Full Article (Word) WJGO-12-182.docx
Manuscript File 51979-Review.docx
Answering Reviewers 51979-Answering reviewers.pdf
Audio Core Tip 51979-Audio core tip.mp3
Biostatistics Review Certificate 51979-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 51979-Conflict-of-interest statement.pdf
Copyright License Agreement 51979-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 51979-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 51979-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 51979-Language certificate.pdf
Supplementary Material 51979-Supplementary material.pdf
Peer-review Report 51979-Peer-review(s).pdf
Scientific Misconduct Check 51979-Scientific misconduct check.pdf
Scientific Editor Work List 51979-Scientific editor work list.pdf